Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mapping lifelong chronic health risks for childhood cancer survivors

2.

High weight and obesity are associated with poor outcomes in leukemia treatment.

3.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link

4.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

5.

Housing aid linked to lower medical financial hardship among US renters with cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot